Log In
Print this Print this

Ii-Key/HER2/neu cancer vaccine (AE37)

  Manage Alerts
Collapse Summary General Information
Company Generex Biotechnology Corp.
DescriptionPeptide vaccine containing li-Key modified HER2/neu protein fragment
Molecular Target Epidermal growth factor receptor 2 (HER2) (EGFR2) (ErbB2) (neu)
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today